TSH Biopharm Competitors and Similar CompaniesClear all

TSH Biopharm's competitors and similar companies include Epizyme, Janssen and Loxo Oncology.

	TSH Biopharm TSH Biopharm (東生華製藥股份有限公司) is a pharmaceutical company focused on chronic diseases.	Epizyme Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.	Janssen Janssen is a company providing prescription pharmaceutical products.	Loxo Oncology Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
Founding Date	Founding Date 2010	Founding Date 2007	Founding Date 1953	Founding Date 2013
Type	Type Public	Type Public	Type Subsidiary	Type Subsidiary
Tags	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma
Locations	Locations TW HQ	Locations Cambridge, US HQ	Locations Raritan, US HQ Vienna, AT Prague, CZ Espoo, FI Budapest, HU Oslo, NO Belgrade, RS see more	Locations Stamford, US HQ Alcobendas, ES Boulder, US New York, US South San Francisco, US
Employees	Employees 76	Employees 20364% increase	Employees 17,3684% decrease	Employees 65610% decrease
Financial
Revenue (est.)	Revenue (est.) NT$1.3b (FY, 2025)	Revenue (est.) $37.4m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods NT$629m (FY, 2025)	Cost of goods $10.5m (FY, 2021)	Cost of goods N/A	Cost of goods N/A
Net income	Net income NT$187.8m (FY, 2025)	Net income ($251.1m) (FY, 2021)	Net income N/A	Net income ($148.9m) (FY, 2017)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 51.5m	Total funding raised N/A	Total funding raised $ 57m